ChemComm
Communication
M. Sani, A. Volonterio and M. Zanda, J. Fluorine Chem., 2004,
125, 1735.
3 For a leading review, see: J. Nie, H.-C. Guo, D. Cahard and J.-A. Ma,
Chem. Rev., 2011, 111, 455.
4 For leading references on asymmetric hydrogenation of trifluoro-
methyl imines, see: (a) H. Abe, H. Amii and K. Uneyama, Org. Lett.,
¨ ¨
2001, 3, 313; (b) B. Torok and G. K. S. Prakash, Adv. Synth. Catal.,
2003, 345, 165; (c) M.-W. Chen, Y. Duan, Q.-A. Chen, D.-S. Wang,
C.-B. Yu and Y.-G. Zhou, Org. Lett., 2010, 12, 5075; (d) A. Henseler,
M. Kato, K. Mori and T. Akiyama, Angew. Chem., Int. Ed., 2011,
50, 8180.
Fig. 2 The X-ray structure of ketimine 7a.
5 For leading references on asymmetric reduction of trifluoromethyl
imines, see: (a) P. Bravo, M. Crucianelli and M. Zanda, Tetrahedron
Lett., 1995, 36, 3043; (b) T. Sakai, F. Yan, S. Kashino and
K. Uneyama, Tetrahedron, 1996, 52, 233; (c) S. Fustero, B. Pina,
E. Salavert, A. Navarro, M. C. R. de Arellano and A. S. Fuentes, J. Org.
´
Chem., 2002, 67, 4667; (d) S. Fustero, J. G. Soler, A. Bartolome and
´
M. S. Rosello, Org. Lett., 2003, 5, 2707; (e) F. Gosselin, P. D. O’Shea,
S. Roy, R. A. Reamer, C.-Y. Chen and R. P. Volante, Org. Lett., 2005,
7, 355; ( f ) G. Hughes, P. N. Devine, J. R. Naber, P. D. O’Shea,
B. S. Foster, D. J. McKay and R. P. Volante, Angew. Chem., Int. Ed.,
2007, 46, 1839; (g) Y. Ishida, N. Iwahashi, N. Nishizono and K. Saigo,
Fig. 3 The proposed transition model for transamination.
´
Tetrahedron Lett., 2009, 50, 1889; (h) J. Pytkowicz, O. Stephany,
S. Marinkovic, S. Inagaki and T. Brigaud, Org. Biomol. Chem.,
2010, 8, 4540.
(a potentially useful structure moiety in drug design)2a in 91%
yield and with 94% ee.
6 For leading references on asymmetric nucleophilic addition to
trifluoromethyl imines, see: (a) P. Bravo, M. Guidetti, F. Viani,
M. Zanda, A. L. Markovsky, A. E. Sorochinsky, I. V. Soloshonok
and V. A. Soloshonok, Tetrahedron, 1998, 54, 12789; (b) F. Huguenot
and T. Brigaud, J. Org. Chem., 2006, 71, 2159; (c) C. Lauzon and
A. B. Charette, Org. Lett., 2006, 8, 2743; (d) V. L. Truong,
A precise understanding of the origin of the enantioselectivity
awaits further study. Based on the X-ray structure of ketimine
7a (Fig. 2), a plausible transition state model is proposed in
Fig. 3. The NH group is likely to form a hydrogen bond with
the imine of the substrate to facilitate the deprotonation. The
4-NO2 group on the aniline may increase the acidity of the NH
group and consequently enhance the hydrogen bonding. The
(S)-trifluoromethyl aldimine is disfavored probably due to
the unfavorable interaction between the isopropyl group of
the catalyst and the trifluoromethyl group of the substrate in
transition state B.
In summary, we have developed an efficient quinine-derived
chiral base-catalyzed asymmetric [1,3]-proton shift process
for trifluoromethyl ketimines to produce a wide variety of
trifluoromethyl aldimines in 92–99% yield and with up to
94% ee. The resulting aldimine can be readily converted to
optically active trifluoromethyl amine. The current process
further demonstrates that organocatalytic biomimetic transa-
mination provides a useful approach to synthesize optically
active amine derivatives from carbonyl compounds. The develop-
ment of more effective catalytic systems and the expansion of
other carbonyl substrates are currently underway.
´
M. S. Menard and I. Dion, Org. Lett., 2007, 9, 683; (e) P. Fu,
M. L. Snapper and A. H. Hoveyda, J. Am. Chem. Soc., 2008,
130, 5530; ( f ) G.-W. Zhang, L. Wang, J. Nie and J.-A. Ma, Adv. Synth.
Catal., 2008, 350, 1457; (g) Q.-Y. Zhao, Z.-L. Yuan and M. Shi, Adv.
Synth. Catal., 2011, 353, 637; (h) N. Hara, R. Tamura, Y. Funahashi
and S. Nakamura, Org. Lett., 2011, 13, 1662; (i) J. Xu, Z.-J. Liu,
X.-J. Yang, L.-M. Wang, G.-L. Chen and J.-T. Liu, Tetrahedron, 2010,
66, 8933.
7 For leading references on asymmetric nucleophilic addition to
imines with the trifluoromethyl group as a nucleophile, see:
(a) G. K. S. Prakash, M. Mandal and G. A. Olah, Angew. Chem., Int.
Ed., 2001, 40, 3; (b) H. Kawai, A. Kusuda, S. Nakamura, M. Shiro and
N. Shibata, Angew. Chem., Int. Ed., 2009, 48, 6324.
8 For leading references on chiral base-catalyzed isomerization of
trifluoromethyl imines, see: (a) V. A. Soloshonok, A. G. Kirilenko,
S. V. Galushko and V. P. Kukhar, Tetrahedron Lett., 1994, 35, 5063;
(b) V. A. Soloshonok and V. P. Kukhar, Tetrahedron, 1996, 52, 6953;
(c) V. A. Soloshonok and M. Yasumoto, J. Fluorine Chem., 2007,
128, 170; (d) V. Michaut, F. Metz, J.-M. Paris and J.-C. Plaquevent,
J. Fluorine Chem., 2007, 128, 500; (e) J. Han, A. E. Sorochinsky,
T. Ono and V. A. Soloshonok, Curr. Org. Synth., 2011, 8, 281.
9 For leading references on isomerization of chiral trifluoromethyl
imine, see: (a) V. A. Soloshonok and T. Ono, J. Org. Chem., 1997,
62, 3030; (b) V. A. Soloshonok, T. Ono and I. V. Soloshonok, J. Org.
Chem., 1997, 62, 7538; (c) V. A. Soloshonok and V. P. Kukhar,
Tetrahedron, 1997, 53, 8307; (d) J. Xiao and C. Yuan, Heteroat. Chem.,
2000, 11, 541; (e) V. A. Soloshonok, H. Ohkura and M. Yasumoto,
J. Fluorine Chem., 2006, 127, 924; ( f ) V. A. Soloshonok, H. Ohkura
and M. Yasumoto, J. Fluorine Chem., 2006, 127, 930; (g) V. A.
Soloshonok, H. T. Catt and T. Ono, J. Fluorine Chem., 2009,
130, 512; (h) V. A. Soloshonok, H. T. Catt and T. Ono, J. Fluorine
Chem., 2010, 131, 261.
The authors gratefully acknowledge the National Basic
Research Program of China (973 program, 2010CB833300)
and the Chinese Academy of Sciences for the financial support.
Notes and references
10 (a) X. Xiao, Y. Xie, C. Su, M. Liu and Y. Shi, J. Am. Chem. Soc., 2011,
133, 12914; (b) F. Xue, X. Xiao, H. Wang and Y. Shi, Tetrahedron,
2012, 68, 6862; (c) X. Xiao, M. Liu, C. Rong, F. Xue, S. Li, Y. Xie and
Y. Shi, Org. Lett., 2012, 14, 5270, for transamination of aromatic
ketones, see: (d) Y. Xie, H. Pan, X. Xiao, S. Li and Y. Shi, Org. Biomol.
Chem., 2012, 10, 8960.
1 For a recent book, see: K. Uneyama, in Fluorine in Medicinal
Chemistry and Chemical Biology, ed. I. Ojima, Blackwell Publishing,
Ltd., 2009, ch. 9.
2 For selected examples, see: (a) Y. Kohno, K. Awano, M. Miyashita,
T. Ishizaki, K. Kuriyama, Y. Sakoe, S. Kudoh, K. Saito and E. Kojima,
Bioorg. Med. Chem. Lett., 1997, 7, 1519; (b) M. Molteni, A. Volonterio 11 Y. Wu and L. Deng, J. Am. Chem. Soc., 2012, 134, 14334.
and M. Zanda, Org. Lett., 2003, 5, 3887; (c) M. Molteni, C. Pesenti, 12 A. S. Guram and S. L. Buckwald, J. Am. Chem. Soc., 1994, 116, 7901.
c
1406 Chem. Commun., 2013, 49, 1404--1406
This journal is The Royal Society of Chemistry 2013